CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $37,000 | +5.7% | 20,054 | +53.1% | 0.00% | 0.0% |
| Q1 2022 | $35,000 | -63.5% | 13,101 | -13.7% | 0.00% | -66.7% |
| Q2 2021 | $96,000 | -87.0% | 15,182 | -84.1% | 0.00% | -89.3% |
| Q1 2021 | $737,000 | +504.1% | 95,284 | +552.9% | 0.03% | +250.0% |
| Q2 2020 | $122,000 | +14.0% | 14,595 | +5.0% | 0.01% | -11.1% |
| Q1 2020 | $107,000 | -29.1% | 13,900 | +39.0% | 0.01% | -59.1% |
| Q4 2018 | $151,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |